Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 28 (4), 315-327
- https://doi.org/10.1016/0010-7824(83)90033-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Serum Lipoprotein and Apolipoprotein Changes During Treatment with a Contraceptive Vaginal Ring Containing Levonorgestrel and EstradiolActa Obstetricia et Gynecologica Scandinavica, 1982
- The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiolContraception, 1981
- A multicenter study of levonorgestrel—Estradiol contraceptive vaginal rings III — Menstrual patternsContraception, 1981
- A multicenter study of levonorgestrel—Estradiol contraceptive vaginal rings II — Subjective and objective measures of effectsContraception, 1981
- A multicenter study of levonorgestrel—Estradiol contraceptive vaginal rings I — Use effectivenessContraception, 1981
- Levonorgestrel and estradiol release from an improved contraceptive vaginal ringContraception, 1981
- Reduction of high density lipoprotein cholesterol and apolipoprotein a-i concentrations by a lipid-lowering dietAtherosclerosis, 1980
- PLASMA LEVELS OF NORETHINDRONE AFTER SINGLE ORAL DOSE ADMINISTRATION OF NORETHINDRONE AND LYNESTRENOLClinical Endocrinology, 1979
- Vaginal Progesterone for ContraceptionFertility and Sterility, 1978
- Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrelAmerican Journal of Obstetrics and Gynecology, 1978